Skip to main content
Top
Published in: Reactions Weekly 1/2020

01-06-2020 | Cerebral Hemorrhage | Case report

Imatinib

Development of drug resistance: case report

Published in: Reactions Weekly | Issue 1/2020

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Ma C-C, et al. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia. Journal of International Medical Research 48: No. 5, 05 May 2020. Available from: URL: http://doi.org/10.1177/0300060520919237 Ma C-C, et al. Clonal evolution of AML1-ETO coexisting with BCR-ABL and additional chromosome abnormalities in a blastic transformation of chronic myeloid leukemia. Journal of International Medical Research 48: No. 5, 05 May 2020. Available from: URL: http://​doi.​org/​10.​1177/​0300060520919237​
Metadata
Title
Imatinib
Development of drug resistance: case report
Publication date
01-06-2020
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2020
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-79912-5

Other articles of this Issue 1/2020

Reactions Weekly 1/2020 Go to the issue

Case report

Antineoplastics

Case report

Ciclosporin

Case report

Azathioprine